Kymera Therapeutics, Inc.

This early-stage study tested a new oral medication called KT-621 for adults with moderate to severe eczema. The main goals were to check if the pill was safe and how the body processed it. Researchers enrolled 22 participants to take the drug and monitored them closely for side …

This was the first study to give the experimental oral drug KT-621 to people. Its main goal was to check if the drug is safe and how the body absorbs and processes it. The study involved 118 healthy adult volunteers who received either the drug or a placebo. Researchers measured …